Disclosed is a glucose measuring apparatus including a pressure measurer having an elastic part or a pressure sensor, that measures a pressure applied to an object, a film that comprises a first optical waveguide configured to be close to the object, a near infrared ray (NIR) irradiator that irradiates an NIR to the first optical waveguide if the measured pressure is greater than or equal to a preset value, an NIR receiver that receives an attenuated total reflection NIR (ATR-NIR) from the first optical waveguide, and an analyzer that measures a blood glucose level based on the ATR-NIR, wherein the film is an independent module that can be combined with and separated from the glucose measuring apparatus.

Methods and systems for autonomous cardiac mapping are disclosed. An example system for autonomous cardiac mapping of a heart chamber includes a processor being configured to acquire a representative geometric shell of the heart chamber, control a robotic device to autonomously navigate a mapping probe to a plurality of locations within the heart chamber based at least in part on the representative geometric shell, and generate a three-dimensional electroanatomical map of the heart chamber based on electrical data collected by the probe at the plurality of locations.

Methods and systems are provided for lowering power consumption in an optical sensor, such as a pulse oximeter. In one example, a method for an optical sensor includes illuminating a light emitter of the optical sensor according to set sensor parameters, the sensor parameters set based on hardware noise or external interference characterization and light transmission or reflection of a tissue contributing to a signal output by the optical sensor, the sensor parameters including current drive parameters of the light emitter, and adjusting the current drive parameters of the light emitter to maintain a target signal to noise ratio of the signal output by the optical sensor.

A body-wearable garment having a hood activated speaker is provided. The body-wearable garment comprises a hood. The body-wearable garment further comprises a speaker integrated within the hood. The speaker is activated in response to receiving a signal from a sensor indicating that the hood is in a deployed state.

Apparatuses and methods for displaying a blood pressure monitoring instrument reading along with inaccuracy values that vary over apparatus life and according to current operating conditions are disclosed. These inaccuracy values account for variability under different operating environments, over time and number of device measurement cycles, and across the range of possible instrument reading conditions. Determination of inaccuracy values may be based both on apparatus history and measurement under the current operating condition. Methods can further include informing a user of confidence in the instrument's current measurements based on the instrument's measurements and inaccuracy.

A method and an apparatus for assessing cardiopulmonary fitness of a user are provided. A method of assessing cardiopulmonary fitness involves measuring a biosignal of a user performing an activity, measuring an exercise intensity of the activity, determining a parameter based on the biosignal and the exercise intensity, estimating a cardiopulmonary fitness index based on the parameter, and assessing the cardiopulmonary fitness of the user based on the cardiopulmonary fitness index.

Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.

Systems and methods for wireless communication of analyte information are disclosed. Example embodiments include an analyte sensor system. The analyte sensor system may include an analyte sensor to gather information related to a level of an analyte in a host. The analyte sensor system may include circuitry to transmit and receive wireless signals using a first antenna. The analyte sensor may be coupled to the circuitry before the analyte sensor system is transitioned into an operational state. The analyte sensor system may include a second antenna to receive an input signal from a source external to the analyte sensor system and to transmit a modified signal. The circuitry may use the first antenna to receive the modified signal. The analyte sensor system may transition into the operational state in response to the modified signal received using the first antenna.

An oral care device (10) assesses a health parameter of gingival tissue of a user by means of a force-generating module (52) to apply a momentary force to the gingival tissue by applying a burst of compressed air or a burst of liquid to the gingival tissue, a sensor (28) to obtain a plurality of optical signals from the gingival tissue over time after the momentary force has been applied, a controller (30) to quantify, based at least in part on an analysis of the plurality of optical signals, the health parameter (e.g. inflammation of the gingival tissue), wherein the health parameter is based at least in part on an amount of time the gingival tissue takes to recover to the application of force; and a feedback module (46) to provide information to the user regarding the quantified health parameter.

Provided are a method of controlling a wearable device and a wearable device. The method of controlling the wearable device includes: determining whether a sensor provided in the wearable device is in an activated state; controlling an adherency controller for adjusting adherency between the sensor and a body of a user wearing the wearable device based on whether the sensor is in the activated state; and detecting a biosignal via the sensor.